日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma

纳武利尤单抗联合伊匹木单抗治疗转移性变异型(非透明细胞)肾细胞癌患者的疗效和安全性

Moussa, Mohammad Jad; Khandelwal, Jaanki; Wilson, Nathaniel R; Malikayil, Kiran L; Surasi, Devaki Shilpa; Bathala, Tharakeswara K; Lin, Yiyun; Rao, Priya; Tamboli, Pheroze; Sircar, Kanishka; Ajufo, Helen; Elsayes, Khaled M; Shah, Amishi; Johns, Andrew C; Goswami, Sangeeta; Hasanov, Elshad; Jonasch, Eric; Msaouel, Pavlos; Campbell, Matthew T; Alhalabi, Omar; Tannir, Nizar M

Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy

鲁比替定治疗TP53突变型小细胞膀胱癌的持久客观疗效:一种分子靶向策略

Moussa, Mohammad Jad; Khandelwal, Jaanki; Wilson, Nathaniel R; Naik, Sagar A; Subbiah, Vivek; Campbell, Matthew T; Msaouel, Pavlos; Singh, Parminder; Alhalabi, Omar

Arginine substitution of a cysteine in transmembrane helix M8 converts Na+,K+-ATPase to an electroneutral pump similar to H+,K+-ATPase

跨膜螺旋M8中半胱氨酸被精氨酸取代,使Na+,K+-ATPase转变为类似于H+,K+-ATPase的电中性泵。

Holm, Rikke; Khandelwal, Jaanki; Einholm, Anja P; Andersen, Jens P; Artigas, Pablo; Vilsen, Bente